Different Low-flow Sevoflurane Anesthesia Techniques
Comparison of the Consumption of Sevoflurane in Two Different Concentrations and Two Different Currents During the Initial Period of Anesthesia in Patients Undergoing General Anesthesia With Minimal Flow
1 other identifier
observational
60
1 country
1
Brief Summary
After reaching 1 MAC level with 4 lt / min fresh gas flow and 2.5% sevoflurane concentration in the initial stage in 35 patients, anesthesia maintenance will be continued with 0.5 lt / min fresh gas flow and 2 -4% sevoflurane concentration with the target of 1 MAC. For 35 patients, after reaching 1 (MAC) level with 1 lt / min fresh gas flow and 8% sevoflurane concentration in the initial phase, maintenance of anesthesia will be continued with 0.5 lt / min fresh gas flow and 2 -4% sevoflurane concentration, targeting 1 MAC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2021
CompletedStudy Start
First participant enrolled
February 5, 2021
CompletedFirst Posted
Study publicly available on registry
February 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2021
CompletedSeptember 1, 2021
August 1, 2021
3 months
February 2, 2021
August 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
sevoflurane versus desflurane
To compare the instant and total consumption of sevoflurane using 2 different concentrations and different minute / fresh gas flow to fill the system in the initial phase of anesthesia.
the study will comlete in one month
Secondary Outcomes (1)
sevoflurane
studdy will complete in one month
Study Arms (2)
sevoflurane 8 %
In the initial phase, after reaching 1 (MAK) level with 1lt / min fresh gas flow and 8% sevoflurane concentration, anesthesia maintenance will be continued with 0.5 lt / min fresh gas flow and 2 -4% sevoflurane concentration with the target of 1 MAC.
sevoflurane 2.5 %
In the initial phase, after reaching 1 MAK level with 4 lt / min fresh gas flow and 2.5% sevoflurane concentration, anesthesia maintenance will be continued with 0.5 lt / min fresh gas flow and 2 -4% sevoflurane concentration with the target of 1 MAC.
Interventions
for 35 patients after reaching 1 MAK level with 4 lt / min fresh gas flow and 2,5% sevoflurane concentration in the initial phase, maintenance of anesthesia will be continued with 0.5 lt / min fresh gas flow and 2 -4% sevoflurane concentration with the target of 1 minimum alveolar concentration
For 35 patients after reaching 1 (MAC) level with 1 lt / min fresh gas flow and 8% sevoflurane concentration in the initial phase, maintenance of anesthesia will be continued with 0.5 lt / min fresh gas flow and 2 -4% sevoflurane concentration, targeting 1 MAC. .
Eligibility Criteria
* Patients between the ages of 18-65 * ASA1,2,3 group patients
You may qualify if:
- Patients between the ages of 18-65
- ASA1,2,3 group patients
- Patients under general anesthesia
- Patients scheduled for elective surgery
You may not qualify if:
- The patient's refusal to participate in the study
- Patients with less than 90 minutes of total anesthesia time
- Patients whose total anesthesia time exceeds 180 minutes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tahsin Şimşek
Istanbul, Kartal, 34000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
February 2, 2021
First Posted
February 8, 2021
Study Start
February 5, 2021
Primary Completion
April 28, 2021
Study Completion
May 15, 2021
Last Updated
September 1, 2021
Record last verified: 2021-08